A detailed history of Rothschild Investment LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Rothschild Investment LLC holds 90,968 shares of NVO stock, worth $9.58 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
90,968
Previous 83,844 8.5%
Holding current value
$9.58 Million
Previous $12 Billion 9.49%
% of portfolio
0.71%
Previous 0.83%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$119.07 - $145.42 $848,254 - $1.04 Million
7,124 Added 8.5%
90,968 $10.8 Billion
Q2 2024

Jul 30, 2024

BUY
$122.71 - $146.91 $10.3 Million - $12.3 Million
83,844 New
83,844 $12 Billion
Q1 2024

Jul 31, 2024

BUY
$102.11 - $135.92 $29,407 - $39,144
288 Added 0.39%
73,591 $9.45 Billion
Q4 2023

Jul 31, 2024

SELL
$87.78 - $105.45 $925,288 - $1.11 Million
-10,541 Reduced 12.57%
73,303 $7.58 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.